Voyager Therapeutics (VYGR)

• Market cap: $186M
• 1 day: -0.30%
• 5 days: -11.32%
• 1 month: -13.81%
• 3 months: -43.55%
• 6 months: -42.39%
• Year to date: -43.55%
• 1 year: -68.03%
• 5 years: -58.14%
• 10 years: -81.01%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 18

19% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 37

2% more funds holding

Funds holding: 128 [Q3] → 130 (+2) [Q4]

1.75% less ownership

Funds ownership: 64.92% [Q3] → 63.16% (-1.75%) [Q4]

6% less capital invested

Capital invested by funds: $207M [Q3] → $196M (-$11.9M) [Q4]

42% less call options, than puts

Call options by funds: $273K | Put options by funds: $474K

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $10 197% upside
• Avg. target: $17.33 414% upside
• High target: $30 790% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

Canaccord Genuity Sumant Kulkarni 22% 1-year accuracy 7 / 32 met price target	256% upside $12	Buy Maintained	13 Mar 2025
HC Wainwright & Co. Patrick Trucchio 21% 1-year accuracy 38 / 181 met price target	790% upside $30	Buy Reiterated	13 Mar 2025
Wells Fargo Yanan Zhu 6% 1-year accuracy 1 / 17 met price target	197% upside $10	Overweight Maintained	12 Mar 2025